17 Aug Clozapine – Induced gastrointestinal hypomotility
Posted at 13:06h
in
In collaboration with the South African Health Products Regulatory Authority (SAHPRA) Novartis, Litha Pharma and Aspen Pharmacare, would like to remind you of the following labelled safety information regarding the safe use of clozapine as contained in:
2019 Apr
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
17/04/2019
File Type:
pdf
Category:
Communication To Health Care Professionals